Characterization of the Analgesic Effects of Oral CBD in Healthy, Normal Volunteers
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 12 Apr 2018
At a glance
- Drugs Cannabidiol (Primary)
- Indications Dravet syndrome; Drug abuse; Epilepsy; Glioblastoma; Infantile spasms; Lennox-Gastaut syndrome; Peripheral nervous system diseases
- Focus Therapeutic Use
- 09 Apr 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.
- 10 Aug 2017 Status changed from recruiting to active, no longer recruiting.
- 20 Sep 2016 Status changed from not yet recruiting to recruiting.